miR-143 and miR-145 inhibit stem cell characteristics of PC-3 prostate cancer cells

Oncology Reports

Volumn 28, Issue 5, 2012, Pages 1831-1837

  Huang, Shuai ^a   Guo, Wei ^a   Tang, Yubo ^a   Ren, Dong ^a   Zou, Xuenong ^a   Peng, Xinsheng ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Bone metastasis; Cancer stem cell; microRNAs; Prostate cancer cells; Stemness

Indexed keywords

CD133 ANTIGEN; HERMES ANTIGEN; KRUPPEL LIKE FACTOR 4; MICRORNA 143; MICRORNA 145; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE METASTASIS; CANCER CELL CULTURE; CANCER INVASION; CANCER STEM CELL; CELL VIABILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MIGRATION INHIBITION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION;

ANTIGENS, CD; ANTIGENS, CD44; BONE NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; EPITHELIAL-MESENCHYMAL TRANSITION; GLYCOPROTEINS; HEK293 CELLS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASTIC STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3; PEPTIDES; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MYC; SPHEROIDS, CELLULAR;

EID: 84866464390     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2015     Document Type: Article

References (45)

1. Landis SH, Murray T, Bolden S and Wingo PA: Cancer statistics, 1999. CA Cancer J Clin 49: 8-31, 1999. (Pubitemid 29094959)
2. Bubendorf L, Schopfer A, Wagner U, et al: Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol 31: 578-583, 2000. (Pubitemid 30323983)
3. Shah RB, Mehra R, Chinnaiyan AM, et al: Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program. Cancer Res 64: 9209-9216, 2004. (Pubitemid 39665537)
4. Rana A, Chisholm GD, Khan M, Sekharjit SS, Merrick MV and Elton RA: Patterns of bone metastasis and their prognostic significance in patients with carcinoma of the prostate. Br J Urol 72: 933-936, 1993. (Pubitemid 24053517)
5. Inui M, Martello G and Piccolo S: MicroRNA control of signal transduction. Nat Rev Mol Cell Biol 11: 252-263, 2010.
6. Schickel R, Boyerinas B, Park SM and Peter ME: MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 27: 5959-5974, 2008.
7. Baranwal S and Alahari SK: miRNA control of tumor cell invasion and metastasis. Int J Cancer 126: 1283-1290, 2010.
8. Garzon R, Calin GA and Croce CM: MicroRNAs in cancer. Annu Rev Med 60: 167-179, 2009.
9. Khew-Goodall Y and Goodall GJ: Myc-modulated miR-9 makes more metastases. Nat Cell Biol 12: 209-211, 2010.
10. Nicoloso MS, Spizzo R, Shimizu M, Rossi S and Calin GA: MicroRNAs - the micro steering wheel of tumour metastases. Nat Rev Cancer 9: 293-302, 2009.
11. Li T, Li D, Sha J, Sun P and Huang Y: MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. Biochem Biophys Res Commun 383: 280-285, 2009.
12. Spahn M, Kneitz S, Scholz CJ, et al: Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence. Int J Cancer 127: 394-403, 2010.
13. Kong D, Banerjee S, Ahmad A, et al: Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells. PLoS One 5: e12445, 2010.
14. Liu C, Kelnar K, Liu B, et al: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med 17: 211-215, 2011.
15. Kong D, Heath E, Chen W, et al: Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIM. PLoS One 7: e33729. 2012.
16. Peng X, Guo W, Liu T, et al: Identification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMT. PLoS One 6: e20341, 2011.
17. Su YJ, Lai HM, Chang YW, Chen GY and Lee JL: Direct reprogramming of stem cell properties in colon cancer cells by CD44. EMBO J 30: 3186-3199, 2011.
18. Clarke MF, Dick JE, Dirks PB, et al: Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66: 9339-9344, 2006.
19. Sun S and Wang Z: ALDH high adenoid cystic carcinoma cells display cancer stem cell properties and are responsible for mediating metastasis. Biochem Biophys Res Commun 396: 843-848, 2010.
20. Visvader JE and Lindeman GJ: Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8: 755-768, 2008.
21. Chaffer CL and Weinberg RA: A perspective on cancer cell metastasis. Science 331: 1559-1564, 2011.
22. Monteiro J and Fodde R: Cancer stemness and metastasis: therapeutic consequences and perspectives. Eur J Cancer 46: 1198-1203, 2010.
23. Hatfield S and Ruohola-Baker H: microRNA and stem cell function. Cell Tissue Res 331: 57-66, 2008. (Pubitemid 50001378)
24. Xu N, Papagiannakopoulos T, Pan G, Thomson JA and Kosik KS: MicroRNA-145 regulates OCT-4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 137: 647-658, 2009.
25. Wong DJ, Segal E and Chang HY: Stemness, cancer and cancer stem cells. Cell Cycle 7: 3622-3624, 2008.
26. Zhang S, Balch C, Chan MW, et al: Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 68: 4311-4320, 2008.
27. Pfeiffer MJ and Schalken JA: Stem cell characteristics in prostate cancer cell lines. Eur Urol 57: 246-254, 2010.
28. Yang M, Burton DW, Geller J, et al: The bisphosphonate olpadronate inhibits skeletal prostate cancer progression in a green fluorescent protein nude mouse model. Clin Cancer Res 12: 2602-2606, 2006.
29. Bisson I and Prowse DM: WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics. Cell Res 19: 683-697, 2009.
30. Patrawala L, Calhoun T, Schneider-Broussard R, et al: Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 25: 1696-1708, 2006.
31. Trerotola M, Rathore S, Goel HL, et al: CD133, Trop-2 and alpha2beta1 integrin surface receptors as markers of putative human prostate cancer stem cells. Am J Transl Res 2: 135-144, 2010.
32. Zöller M: CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer 11: 254-267, 2011.
33. Schoenhals M, Kassambara A, De Vos J, Hose D, Moreaux J and Klein B: Embryonic stem cell markers expression in cancers. Biochem Biophys Res Commun 383: 157-162, 2009.
34. Liu C and Tang DG: MicroRNA regulation of cancer stem cells. Cancer Res 71: 5950-5954, 2011.
35. Sachdeva M, Zhu S, Wu F, et al: p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Aca Sci USA 106: 3207-3212, 2009.
36. Yang YP, Chien Y, Chiou GY, Cherng JY, Wang ML, Lo WL, et al: Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI. Biomaterials 33: 1462-1476, 2012.
37. Chiou GY, Cherng JY, Hsu HS, et al: Cationic polyurethanes-short branch PEI-mediated delivery of Mir145 inhibited epithelial-mesenchymal transdifferentiation and cancer stem-like properties and in lung adenocarcinoma. J Control Release 159: 240-250, 2012.
38. Lee MY, Lu A and Gudas LJ: Transcriptional regulation of Rex1 (zfp42) in normal prostate epithelial cells and prostate cancer cells. J Cell Physiol 224: 17-27, 2010.
39. Hayashida T, Jinno H, Kitagawa Y and Kitajima M: Cooperation of cancer stem cell properties and epithelial-mesenchymal transition in the establishment of breast cancer metastasis. J Oncol 2011: 591427, 2011.
40. Mani SA, Guo W, Liao MJ, et al: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715, 2008. (Pubitemid 351636299)
41. Morel AP, Lièvre M, Thomas C, Hinkal G, Ansieau S and Puisieux A: Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 3: e2888, 2008.
42. Pirozzi G, Tirino V, Camerlingo R, et al: Epithelial to mesenchymal transition by TGFβ-1 induction increases stemness characteristics in primary non small cell lung cancer cell line. PLoS One 6: e21548, 2011.
43. Li H, Chen X, Calhoun-Davis T, Claypool K and Tang DG: PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells. Cancer Res 68: 1820-1825, 2008. (Pubitemid 351416567)
44. low increase tumor angiogenesis. Mol Cancer 9: 319, 2010.
45. Morton RA, Ewing CM, Nagafuchi A, Tsukita S and Isaacs WB: Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells. Cancer Res 53: 3585-3590, 1993. (Pubitemid 23229641)